Merck
CN
  • Aspirated bile: a major host trigger modulating respiratory pathogen colonisation in cystic fibrosis patients.

Aspirated bile: a major host trigger modulating respiratory pathogen colonisation in cystic fibrosis patients.

European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology (2014-05-13)
F J Reen, D F Woods, M J Mooij, M N Chróinín, D Mullane, L Zhou, J Quille, D Fitzpatrick, J D Glennon, G P McGlacken, C Adams, F O'Gara
摘要

Chronic respiratory infections are a leading global cause of morbidity and mortality. However, the molecular triggers that cause respiratory pathogens to adopt persistent and often untreatable lifestyles during infection remain largely uncharacterised. Recently, bile aspiration caused by gastro-oesophageal reflux (GOR) has emerged as a significant complication associated with respiratory disease, and cystic fibrosis (CF) in particular. Based on our previous finding that the physiological concentrations of bile influence respiratory pathogens towards a chronic lifestyle in vitro, we investigated the impact of bile aspiration on the lung microbiome of respiratory patients. Sputum samples (n = 25) obtained from a cohort of paediatric CF patients were profiled for the presence of bile acids using high-resolution liquid chromatography-mass spectrometry (LC-MS). Pyrosequencing was performed on a set of ten DNA samples that were isolated from bile aspirating (n = 5) and non-bile aspirating (n = 5) patients. Both denaturing gradient gel electrophoresis (DGGE) and pyrosequencing revealed significantly reduced biodiversity and richness in the sputum samples from bile aspirating patients when compared with non-aspirating patients. Families and genera associated with the pervasive CF microbiome dominated aspirating patients, while bacteria associated with the healthy lung were most abundant in non-aspirating patients. Bile aspiration linked to GOR is emerging as a major host trigger of chronic bacterial infections. The markedly reduced biodiversity and increased colonisation by dominant proteobacterial CF-associated pathogens observed in the sputum of bile aspirating patients suggest that bile may play a major role in disease progression in CF and other respiratory diseases.

材料
货号
品牌
产品描述

Sigma-Aldrich
乙腈, suitable for HPLC, gradient grade, ≥99.9%
Sigma-Aldrich
甲醇, suitable for HPLC, ≥99.9%
Sigma-Aldrich
乙腈, anhydrous, 99.8%
Sigma-Aldrich
甲醇, ACS reagent, ≥99.8%
Sigma-Aldrich
甲醇, anhydrous, 99.8%
Sigma-Aldrich
甲醇, HPLC Plus, ≥99.9%
Sigma-Aldrich
甲醇, suitable for HPLC, gradient grade, ≥99.9%
Sigma-Aldrich
乙腈, ACS reagent, ≥99.5%
Sigma-Aldrich
甲醇, suitable for HPLC, gradient grade, suitable as ACS-grade LC reagent, ≥99.9%
Sigma-Aldrich
乙腈, for HPLC, for UV, ≥99.9% (GC)
Sigma-Aldrich
乙腈, suitable for HPLC, gradient grade, ≥99.9%
Sigma-Aldrich
甲醇, puriss. p.a., ACS reagent, reag. ISO, reag. Ph. Eur., ≥99.8% (GC)
Supelco
甲醇, Pharmaceutical Secondary Standard; Certified Reference Material
USP
木精, United States Pharmacopeia (USP) Reference Standard
Supelco
甲醇, analytical standard
Sigma-Aldrich
甲醇, Laboratory Reagent, ≥99.6%
Sigma-Aldrich
脱氧胆酸, ≥98% (HPLC)
Sigma-Aldrich
甲醇, ACS spectrophotometric grade, ≥99.9%
Supelco
乙腈, Pharmaceutical Secondary Standard; Certified Reference Material
Sigma-Aldrich
鹅去氧胆酸
Sigma-Aldrich
石胆酸, ≥95%
Sigma-Aldrich
熊去氧胆酸, ≥99%
Sigma-Aldrich
胆酸, from bovine and/or ovine, ≥98%
Sigma-Aldrich
乙腈, suitable for HPLC-GC, ≥99.8% (GC)
Sigma-Aldrich
甲醇, BioReagent, ≥99.93%
Sigma-Aldrich
甲醇, ACS reagent, ≥99.8%
Sigma-Aldrich
甲醇, puriss., meets analytical specification of Ph Eur, ≥99.7% (GC)
Supelco
乙腈, analytical standard
Sigma-Aldrich
脱氧胆酸, ≥99.0% (T)
Sigma-Aldrich
乙腈, biotech. grade, ≥99.93%